5914 Results

People

  1. Ladanyi
    Ladanyi
  2. Solit
    Solit
  3. Levine
    Levine
  4. Berger
    Berger
  5. Schultz
    Schultz
  6. Arcila
    Arcila
  7. Hakimi
    Hakimi
  8. Chandarlapaty
    Chandarlapaty
  9. Zehir
    Zehir
  10. Mellinghoff
    Mellinghoff

Groups

  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)
  7. Sloan Kettering Institute Postdocs (1984)
  8. Hematologic Malignancies, Division of (1879)
  9. Center for Hematologic Malignancies (1845)
  10. Center for Molecular Imaging and Biotechnology (CMIB) (1744)
  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2527)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)

More Groups

People
  1. Marc Ladanyi (1327)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (120)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (263)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (758)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5914)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations
    Journal Article

    Kohsaka, S.; Shukla, N.; Ameur, N.; Ito, T.; Ng, C. K. Y.; Wang, L.; Lim, D. ; Marchetti, A.; Viale, A.; Pirun, M.; more...
    Nature Genetics (2014)

    Fulltext@MSK | Save
  • Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma
    Journal Article

    Hakimi, A. A.; Mano, R.; Ciriello, G.; Gonen, M.; Mikkilineni, N.; Sfakianos, J. P.; Kim, P. H.; Motzer, R. J.; Russo, P.; Reuter, V. E.; more...
    Journal of Urology (2014)

    Fulltext@MSK | Save
  • Clinical heterogeneity of Xp11 translocation renal cell carcinoma: Impact of fusion subtype, age, and stage
    Journal Article

    Ellis, C. L.; Eble, J. N.; Subhawong, A. P.; Martignoni, G.; Zhong, M.; Ladanyi, M.; Epstein, J. I.; Netto, G. J.; Argani, P.
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma
    Journal Article

    Brooks, S. A.; Brannon, A. R.; Parker, J. S.; Fisher, J. C.; Sen, O.; Kattan, M. W.; Hakimi, A. A.; Hsieh, J. J.; Choueiri, T. K.; Tamboli, P.; more...
    European Urology (2014)

    Fulltext@MSK | Save
  • A phase II study of afatinib in patients (pts) with metastatic human epidermal growth factor receptor (HER2)-positive trastuzumab-refractory esophagogastric (EG) cancer
    Meeting Abstract

    Janjigian, Y. Y.; Capanu, M.; Imtiaz, T.; Kelsen, D. P.; Ku, G. Y.; Schattner, M.; Brown, K. T.; Ilson, D. H.; Solit, D. B.; Berger, M. F.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Development of novel metastatic prostate cancer cell lines by "organoid" in vitro culture technology
    Meeting Abstract

    Vela, I.; Gao, D.; Gopalan, A.; Sboner, A.; Undvall, E.; Wanjala, J.; Iaquinta, P.; Wongvipat, J.; Karthaus, W.; Clevers, H.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Targeted sequencing of upper tract urothelial carcinoma
    Meeting Abstract

    Sfakianos, J. P.; Kim, P. H.; Iyer, G.; Cha, E. K.; Zabor, E. C.; Hakimi, A. A.; Scott, S. N.; Ramirez, R.; Hanrahan, A.; Rosenberg, J. E.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Using exon-capture, deep sequencing of high-grade bladder urothelial carcinoma to identify recurrent genetic alterations and potential therapeutic targets
    Meeting Abstract

    Kim, P. H.; Sfakianos, J. P.; Scott, S. N.; Iyer, G.; Cha, E. K.; Al-Ahmadie, H.; Sun, A. J.; Garcia-Grossman, I. R.; Bambury, R. M.; Dalbagni, G.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma
    Meeting Abstract

    Hakimi, A. A.; Ostrovnaya, I.; Jacobsen, A.; Coleman, J. A.; Russo, P.; Mano, R.; Sankin, A.; Motzer, R. J.; Purdue, M.; Pomerantz, M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Integrated analysis of metastatic disease in clear cell renal cell carcinoma: A collaborative TCGA analysis
    Meeting Abstract

    Hakimi, A. A.; Jacobsen, A.; Mano, R.; Gonen, M.; Voss, M. H.; Reuter, V. E.; Rathmell, K.; Maranchie, J. K.; Appleman, L. J.; Tamboli, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save